Kumar, A. H. (2021). Network Pharmacology Analysis of Orally Bioavailable SARS-CoV-2 Protease Inhibitor Shows Synergistic Targets to Improve Clinical Efficacy. Biology, Engineering, Medicine and Science Reports, 7(2), 21–24. https://doi.org/10.5530/bems.7.2.8